Entradas nuevas por omla

La industria farmacéutica será ética o no será

Maite Artés  |  Adelphi Spain

Adelphi es una consultoría que trabaja para la industria farmacéutica desarrollando proyectos de investigación y comunicación en salud.

Está formada por un equipo de profesionales multidisciplinar (médicos, farmacéuticos, biólogos, psicólogos, estadísticos, economistas…) capaces de entender las necesidades de nuestros clientes y...
Read more

Not another boring survey?

Rebecca Marshall-Clarke  |  Adelphi Research UK
The BHBIA Members’ Exchange Forum on Customer Engagement gave us some food for thought. The forum shared some strong views on what we need to consider as an industry to improve the relationships we have with HCPs. With response rates declining and apparent frustration amongst potential...
Read more

“I’ll have whatever he’s having!”

Isn’t it strange how sometimes we make decisions within the blink of an eye? Sometimes we simply seem to follow the crowd and sometimes we seem to make decisions without really thinking at all. In fact, recent academic studies in Cognitive Psychology, Social Psychology and Behavioural Economics suggest that over 90% of our daily decision–making is...
Read more

A perfect digital storm

Kristian Barker  |  Adelphi Research UK
The healthcare industry is continuing to progress at break neck speed. And digital developments are following a similar pattern. The risk here, of course, is that these happen in parallel – but for many pharmaceutical companies, steps are already being taken to embrace the...
Read more

How to include the hard to reach?

Rebecca Marshall-Clarke |  Adelphi Research UK
 Are we in danger of focusing brand strategies only on engaged patients?
Patient–centricity has increasingly become a key element of pharma’s strategic decision–making. We are starting to see evidence that placing the patient at the heart of decisions is transforming pharma brands throughout their...
Read more

Comentarios nuevos por omla

    No hay comentarios de omla todavía.